We are live on ! Find out more
RNS

Robert N. Shapiro Portfolio holdings

AUM $501M
1-Year Est. Return 11.71%
This Fund
S&P 500
This Quarter Est. Return
+4.89%
1 Year Est. Return
+11.71%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$526M
AUM Growth
-$15M
Cap. Flow
-$37.5M
Cap. Flow %
-7.12%
Top 10 Hldgs %
20.82%
Holding
838
New
68
Increased
103
Reduced
223
Closed
70

Top Buys

Rank Stock Value
1
VEA icon
Vanguard FTSE Developed Markets ETF
VEA
+$4.07M
2
PGR icon
Progressive
PGR
+$1.69M
3
ROST icon
Ross Stores
ROST
+$1.49M
4
RPM icon
RPM International
RPM
+$1M
5
CME icon
CME Group
CME
+$603K

Top Sells

Rank Stock Value
1
IRWD icon
Ironwood Pharmaceuticals
IRWD
+$4.61M
2
BRK.A icon
Berkshire Hathaway Class A
BRK.A
+$4.18M
3
IBM icon
IBM
IBM
+$3.38M
4
WMT icon
Walmart Inc
WMT
+$2.64M
5
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
+$2.05M

Sector Composition

Rank Sector Weight
1 Healthcare 14.28%
2 Energy 12.91%
3 Technology 12.8%
4 Industrials 12.53%
5 Financials 11.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KMI icon
426
Kinder Morgan
KMI
$72.9B
$67K 0.01%
1,858
+600
+48% +$20.3K
STAA icon
427
STAAR Surgical
STAA
$1.2B
$67K 0.01%
4,000
– –
VLP
428
DELISTED
Valero Energy Partners LP
VLP
$67K 0.01%
1,338
– –
MCHP icon
429
Microchip Technology
MCHP
$44.2B
$66K 0.01%
2,690
-300
-10% -$7.15K
ADBE icon
430
Adobe
ADBE
$84.3B
$65K 0.01%
900
+700
+350% +$45.2K
TWOU
431
DELISTED
2U Inc
TWOU
$65K 0.01%
+129
New +$54.3K
BHI
432
DELISTED
Baker Hughes
BHI
$65K 0.01%
873
– –
N
433
DELISTED
Netsuite Inc
N
$65K 0.01%
+745
New +$60.1K
SRCL
434
DELISTED
Stericycle Inc
SRCL
$64K 0.01%
543
– –
SLM icon
435
SLM Corp
SLM
$4.56B
$63K 0.01%
7,520
+3,967
+112% +$35K
BMO icon
436
Bank of Montreal
BMO
$124B
$62K 0.01%
850
– –
CSX icon
437
CSX Corp
CSX
$97.8B
$62K 0.01%
6,000
– –
GS icon
438
Goldman Sachs
GS
$317B
$62K 0.01%
370
+315
+573% +$50.8K
ODP
439
DELISTED
ODP
ODP
$62K 0.01%
1,090
– –
PSA icon
440
Public Storage
PSA
$58.8B
$61K 0.01%
354
– –
TK icon
441
Teekay
TK
$973M
$61K 0.01%
975
– –
CRT
442
Cross Timbers Royalty Trust
CRT
$59.5M
$60K 0.01%
1,800
– –
RMTI icon
443
Rockwell Medical
RMTI
$25.8M
$59K 0.01%
45
– –
VRTX icon
444
Vertex Pharmaceuticals
VRTX
$120B
$59K 0.01%
625
+250
+67% +$17.5K
EEP
445
DELISTED
Enbridge Energy Partners
EEP
$59K 0.01%
1,600
– –
HGT
446
DELISTED
Hugoton Royalty Trust
HGT
$59K 0.01%
5,369
– –
PCL
447
DELISTED
PLUM CREEK TIMBER CO (REIT)
PCL
$59K 0.01%
+1,300
New +$56.6K
CLX icon
448
Clorox
CLX
$11.3B
$57K 0.01%
622
– –
HXL icon
449
Hexcel
HXL
$8.29B
$56K 0.01%
1,365
– –
MCK icon
450
McKesson
MCK
$96.5B
$56K 0.01%
300
– –
16 17
18
19 20

Similar funds

LOM
Loeb Offshore Management New York $547M AUM 50.11% 1-Year Est. Return
ABI
Adamant Biomedical Investments Zurich, Switzerland $418M AUM
AGCJ
Alden Global Capital (Jersey) St. Helier, Jersey $415M AUM 31.95% 1-Year Est. Return
ACM
Alistair Capital Management Dallas, Texas $391M AUM 5.89% 1-Year Est. Return
NTP
Nine Ten Partners Evanston, Illinois $308M AUM
MMC
MDV Management Company Menlo Park, California $296M AUM
CAMI
Concord Asset Management (Illinois) Chicago, Illinois $288M AUM 11.06% 1-Year Est. Return
NES
New England Securities New York $285M AUM 7.18% 1-Year Est. Return

Robert N. Shapiro's Q2 2014 Portfolio in Review

As of Q2 2014, Robert N. Shapiro held 838 positions worth $526M, down 2.8% from $541M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Robert N. Shapiro withdrew a net $37.5M in Q2 2014, closing 70 positions and reducing 223 holdings. Its most notable exit was Willis Towers Watson, an estimated $1.19M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 15% a quarter earlier, followed by Energy and Technology.

Against the trend, Robert N. Shapiro opened a new position in Progressive worth $1.73M.

  • Robert N. Shapiro's largest Q2 2014 buy was Progressive: 68,380 shares worth $1.73M.
  • Robert N. Shapiro added most to Vanguard FTSE Developed Markets ETF in Q2 2014, an estimated $4.07M increase.
  • Robert N. Shapiro's biggest Q2 2014 reduction was Ironwood Pharmaceuticals, cutting an estimated $4.61M.
  • Robert N. Shapiro fully exited Willis Towers Watson in Q2 2014, selling an estimated $1.19M.
  • Robert N. Shapiro's ten largest holdings make up 21% of its $526M portfolio in Q2 2014.
  • Robert N. Shapiro opened 68 new positions and closed 70 in Q2 2014.
  • Robert N. Shapiro's portfolio value fell 2.8% quarter-over-quarter to $526M.

Based on Robert N. Shapiro's 13F filing for Q2 2014, filed 11 Sep 2014.